Patents by Inventor Vito SAFINA

Vito SAFINA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition of N-palmitoyl-ethanolamide and Rutin in co-micronized form
    Patent number: 11819511
    Abstract: Described herein is a composition based on N-palmitoyl-ethanolamide and Rutin in co-micronized form. In particular, a composition includes a mixture of palmitoyl-ethanolamide (PEA) and Rutin in co-micronized form in which the PEA/Rutin ratio is between 10:1 and 1:1. Pharmaceutical formulations for the treatment of humans and animals are also described. The composition is useable for the treatment of diseases of arteries and arterioles.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: November 21, 2023
    Assignee: EPITECH GROUP S.P.A.
    Inventors: Francesco Della Valle, Maria Federica Della Valle, Gabriele Marcolongo, Salvatore Cuzzocrea, Vito Safina
  • METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE
    Publication number: 20220304954
    Abstract: The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.
    Type: Application
    Filed: March 26, 2021
    Publication date: September 29, 2022
    Applicant: Epitech Group S.p.A.
    Inventors: Francesco Della Valle, Maria Federica Della Valle, Gabriele Marcolongo, Giuliano Claps, Chiara Gomiero, Vito Safina
  • METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE
    Publication number: 20220304956
    Abstract: The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.
    Type: Application
    Filed: February 7, 2022
    Publication date: September 29, 2022
    Applicant: Epitech Group S.p.A.
    Inventors: Francesco DELLA VALLE, Maria Federica DELLA VALLE, Gabriele MARCOLONGO, Giuliano CLAPS, Chiara GOMIERO, Vito SAFINA, Annalisa NOCE, Salvatore CUZZOCREA, Giuseppe ESPOSITO
  • COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND RUTIN IN CO-MICRONIZED FORM
    Publication number: 20210060047
    Abstract: Described herein is a composition based on N-palmitoyl-ethanolamide and Rutin in co-micronized form. In particular, a composition includes a mixture of palmitoyl-ethanolamide (PEA) and Rutin in co-micronized form in which the PEA/Rutin ratio is between 10:1 and 1:1. Pharmaceutical formulations for the treatment of humans and animals are also described. The composition is useable for the treatment of diseases of arteries and arterioles.
    Type: Application
    Filed: August 25, 2020
    Publication date: March 4, 2021
    Inventors: Francesco DELLA VALLE, Maria Federica DELLA VALLE, Gabriele MARCOLONGO, Salvatore CUZZOCREA, Vito SAFINA